Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CERO CERo Therapeutics Holdings, Inc. Common Stock
$0.00 -18.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CERO stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

CERo Therapeutics Holdings, Inc. Common Stock (CERO)

Loading

Key Stats

Market cap. 293.7K
Enterprise value -669586
Trailing PE 0.00012394645
Forward PE -0.0015337423
PEG Ratio -1.2536855317981E-6
Enterprise to EBITDA 0.037968622609517
Price to book MRQ -0.005668444495014

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Diluted EPS TTM 40.34
Total Cash (MRQ) 937.5K
Current ratio (MRQ) 0.047768467768883
Operating Cash Flow (TTM) -16080250

CERO trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CERO News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.